Drug Channels – Direct-to-Consumer Models: Why They’re Expanding and Where They Deliver the Most Impact
Since early 2024, life sciences organizations have increasingly adopted direct-to-consumer (DTC) models to simplify patient access, reduce costs and address market challenges. While DTC models offer advantages in convenience and market positioning, it also introduces complexities in implementation, compliance and data security.In this Drug Channels Institute article, Vice President of...